Results 141 to 150 of about 4,675 (181)

MEK inhibitors are effective in Erdheim-Chester disease regardless of MAPK pathway mutations. [PDF]

open access: yesLeukemia
Pegoraro F   +8 more
europepmc   +1 more source

Erdheim-Chester Disease Diagnosed by a Pericardial Fluid Cell Block Analysis. [PDF]

open access: yesIntern Med
Inoue I   +7 more
europepmc   +1 more source

Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: a longitudinal registry-based analysis. [PDF]

open access: yesBlood Adv
Marathe PH   +10 more
europepmc   +1 more source

Neurological manifestations of Erdheim-Chester disease and their management: A scoping review. [PDF]

open access: yesMedicine (Baltimore)
Qazi MS   +10 more
europepmc   +1 more source

Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study. [PDF]

open access: yesBlood Adv
Pegoraro F   +6 more
europepmc   +1 more source

Erdheim-Chester Disease

open access: yesJournal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology, 2003
Background: Erdheim–Chester disease is a rare non-Langerhans' cell histiocytosis. Objective: This case report is presented to familiarize clinicians with Erdheim–Chester disease and its differential diagnosis.
Susan E, Lenahan   +2 more
core   +7 more sources

Home - About - Disclaimer - Privacy